CD4 and AIDS: The disadvantages are that the system does not fully recapitulate human disease (e.g., CD4 + T loss, mouse tumor cells), and it cannot be used to study AIDS-associated tumors, as it models a population of patients with stable provirus integration, a controlled infection, and normalized CD4 + T cell counts (e.g., PLWH on ART).